Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥ 32 33 32 33 O
1,800 34 39 34 39 B-lower_bound
cells 40 45 40 45 I-lower_bound
/ 45 46 45 46 I-lower_bound
mm3 46 49 46 49 I-lower_bound

Acquired 0 8 50 58 B-chronic_disease
Immune 9 15 59 65 I-chronic_disease
Deficiency 16 26 66 76 I-chronic_disease
Syndrome 27 35 77 85 I-chronic_disease
( 36 37 86 87 I-chronic_disease
AIDS 37 41 87 91 I-chronic_disease
) 41 42 91 92 I-chronic_disease
based 43 48 93 98 O
upon 49 53 99 103 O
current 54 61 104 111 O
Centers 62 69 112 119 O
for 70 73 120 123 O
Disease 74 81 124 131 O
Control 82 89 132 139 O
( 90 91 140 141 O
CDC 91 94 141 144 O
) 94 95 144 145 O

Bone 0 4 146 150 B-treatment
scan 5 9 151 155 I-treatment
is 10 12 156 158 O
not 13 16 159 162 O
required 17 25 163 171 O
for 26 29 172 175 O
patients 30 38 176 184 O
enrolled 39 47 185 193 O
with 48 52 194 198 O
a 53 54 199 200 O
single 55 61 201 207 O
intermediate 62 74 208 220 O
risk 75 79 221 225 O
factor 80 86 226 232 O
only 87 91 233 237 O
, 91 92 237 238 O
but 93 96 239 242 O
this 97 101 243 247 O
scan 102 106 248 252 O
may 107 110 253 256 O
be 111 113 257 259 O
obtained 114 122 260 268 O
at 123 125 269 271 O
the 126 129 272 275 O
discretion 130 140 276 286 O
of 141 143 287 289 O
the 144 147 290 293 O
treating 148 156 294 302 O
physician 157 166 303 312 O

Clinical 0 8 313 321 B-cancer
stage 9 14 322 327 I-cancer
T1 15 17 328 330 I-cancer
- 17 18 330 331 I-cancer
T2c 18 21 331 334 I-cancer
( 22 23 335 336 I-cancer
AJCC 23 27 336 340 I-cancer
7th 28 31 341 344 I-cancer
edition 32 39 345 352 I-cancer
) 39 40 352 353 I-cancer
within 41 47 354 360 O
90 48 50 361 363 B-upper_bound
days 51 55 364 368 I-upper_bound
of 56 58 369 371 O
registration 59 71 372 384 O

Clinically 0 10 385 395 O
negative 11 19 396 404 O
lymph 20 25 405 410 O
nodes 26 31 411 416 O
evaluated 32 41 417 426 O
by 42 44 427 429 O
imaging 45 52 430 437 O
( 53 54 438 439 O
pelvic 54 60 439 445 B-treatment
+ 61 62 446 447 I-treatment
/- 62 64 447 449 I-treatment
abdominal 65 74 450 459 I-treatment
CT 75 77 460 462 I-treatment
or 78 80 463 465 O
MRI 81 84 466 469 B-treatment
scan 85 89 470 474 I-treatment
) 89 90 474 475 O

Eastern 0 7 476 483 B-clinical_variable
Cooperative 8 19 484 495 I-clinical_variable
Oncology 20 28 496 504 I-clinical_variable
Group(ECOG 29 39 505 515 I-clinical_variable
) 39 40 515 516 I-clinical_variable
Performance 41 52 517 528 I-clinical_variable
status 53 59 529 535 I-clinical_variable
0 60 61 536 537 B-lower_bound
- 61 62 537 538 O
1 62 63 538 539 B-upper_bound

Equivocal 0 9 540 549 B-treatment
bone 10 14 550 554 I-treatment
scan 15 19 555 559 I-treatment
findings 20 28 560 568 O
are 29 32 569 572 O
allowed 33 40 573 580 O
if 41 43 581 583 O
plain 44 49 584 589 O
film 50 54 590 594 O
x 55 56 595 596 O
- 56 57 596 597 O
rays 57 61 597 601 O
are 62 65 602 605 O
negative 66 74 606 614 O
for 75 78 615 618 O
metastasis 79 89 619 629 B-cancer

Evidence 0 8 630 638 O
of 9 11 639 641 O
distant 12 19 642 649 B-cancer
metastases 20 30 650 660 I-cancer

Gleason 0 7 661 668 B-clinical_variable
Score 8 13 669 674 I-clinical_variable
< 14 15 675 676 O
7 16 17 677 678 B-upper_bound

Hemoglobin 0 10 679 689 B-clinical_variable
≥ 11 12 690 691 O
8.0 13 16 692 695 B-lower_bound
g 17 18 696 697 I-lower_bound
/ 18 19 697 698 I-lower_bound
dl 19 21 698 700 I-lower_bound

No 0 2 701 703 O
evidence 3 11 704 712 O
of 12 14 713 715 O
bone 15 19 716 720 B-cancer
metastases 20 30 721 731 I-cancer
( 31 32 732 733 I-cancer
M0 32 34 733 735 I-cancer
) 34 35 735 736 I-cancer
on 36 38 737 739 O
bone 39 43 740 744 B-treatment
scan 44 48 745 749 I-treatment
within 49 55 750 756 O
60 56 58 757 759 B-upper_bound
days 59 63 760 764 I-upper_bound
prior 64 69 765 770 I-upper_bound
to 70 72 771 773 O
registration 73 85 774 786 O

No 0 2 787 789 O
prior 3 8 790 795 B-treatment
prostate 9 17 796 804 I-treatment
cancer 18 24 805 811 I-treatment
therapy 25 32 812 819 I-treatment
such 33 37 820 824 O
as 38 40 825 827 O
: 40 41 827 828 O
prostatectomy 42 55 829 842 B-treatment
, 55 56 842 843 O
cryotherapy 57 68 844 855 B-treatment
, 68 69 855 856 O
chemotherapy 70 82 857 869 B-treatment
or 83 85 870 872 O
hyperthermia 86 98 873 885 B-treatment

No 0 2 886 888 O
prior 3 8 889 894 B-treatment
radiotherapy 9 21 895 907 I-treatment
to 22 24 908 910 O
the 25 28 911 914 O
pelvic 29 35 915 921 O
area 36 40 922 926 O

Pathological 0 12 927 939 O
( 13 14 940 941 O
histologically 14 28 941 955 O
) 28 29 955 956 O
proven 30 36 957 963 O
diagnosis 37 46 964 973 O
of 47 49 974 976 O
prostatic 50 59 977 986 B-cancer
adenocarcinoma 60 74 987 1001 I-cancer
within 75 81 1002 1008 O
365 82 85 1009 1012 B-upper_bound
days 86 90 1013 1017 I-upper_bound
( 91 92 1018 1019 I-upper_bound
1 92 93 1019 1020 I-upper_bound
year 94 98 1021 1025 I-upper_bound
) 98 99 1025 1026 I-upper_bound

Patient 0 7 1027 1034 O
is 8 10 1035 1037 O
able 11 15 1038 1042 O
to 16 18 1043 1045 O
start 19 24 1046 1051 O
proton 25 31 1052 1058 B-treatment
therapy 32 39 1059 1066 I-treatment
or 40 42 1067 1069 O
neo 43 46 1070 1073 B-treatment
- 46 47 1073 1074 I-treatment
adjuvant 47 55 1074 1082 I-treatment
hormonal 56 64 1083 1091 I-treatment
therapy 65 72 1092 1099 I-treatment
, 72 73 1099 1100 O
when 74 78 1101 1105 O
recommended 79 90 1106 1117 O
, 90 91 1117 1118 O
within 92 98 1119 1125 O
12 99 101 1126 1128 B-upper_bound
weeks 102 107 1129 1134 I-upper_bound
of 108 110 1135 1137 O
registration 111 123 1138 1150 O

Patients 0 8 1151 1159 O
must 9 13 1160 1164 O
be 14 16 1165 1167 O
18 17 19 1168 1170 B-lower_bound
years 20 25 1171 1176 I-lower_bound
of 26 28 1177 1179 O
age 29 32 1180 1183 B-age
or 33 35 1184 1186 O
older 36 41 1187 1192 O

Patients 0 8 1193 1201 O
with 9 13 1202 1206 O
2 14 15 1207 1208 B-lower_bound
or 16 18 1209 1211 O
3 19 20 1212 1213 B-upper_bound
risk 21 25 1214 1218 O
factors 26 33 1219 1226 O
will 34 38 1227 1231 O
require 39 46 1232 1239 O
a 47 48 1240 1241 O
negative 49 57 1242 1250 O
bone 58 62 1251 1255 B-treatment
scan 63 67 1256 1260 I-treatment
for 68 71 1261 1264 O
eligibility 72 83 1265 1276 O

Patients 0 8 1277 1285 O
with 9 13 1286 1290 O
high 14 18 1291 1295 O
risk 19 23 1296 1300 O
factors 24 31 1301 1308 O
, 31 32 1308 1309 O
such 33 37 1310 1314 O
as 38 40 1315 1317 O
T3 41 43 1318 1320 B-clinical_variable
, 43 44 1320 1321 O
Gleason 45 52 1322 1329 B-clinical_variable
8 53 54 1330 1331 B-lower_bound
- 54 55 1331 1332 O
10 55 57 1332 1334 B-upper_bound
or 58 60 1335 1337 O
PSA 61 64 1338 1341 B-clinical_variable
> 65 66 1342 1343 O
20ng 67 71 1344 1348 B-lower_bound
/ 71 72 1348 1349 I-lower_bound
mL 72 74 1349 1351 I-lower_bound
who 75 78 1352 1355 O
are 79 82 1356 1359 O
not 83 86 1360 1363 O
considered 87 97 1364 1374 O
candidates 98 108 1375 1385 O
for 109 112 1386 1389 O
pelvic 113 119 1390 1396 B-treatment
lymph 120 125 1397 1402 I-treatment
node 126 130 1403 1407 I-treatment
radiation 131 140 1408 1417 I-treatment
treatment 141 150 1418 1427 I-treatment

Patients 0 8 1428 1436 O
with 9 13 1437 1441 O
lymph 14 19 1442 1447 O
nodes 20 25 1448 1453 O
equivocal 26 35 1454 1463 O
or 36 38 1464 1466 O
questionable 39 51 1467 1479 O
by 52 54 1480 1482 O
imaging 55 62 1483 1490 O
are 63 66 1491 1494 O
eligible 67 75 1495 1503 O
without 76 83 1504 1511 O
biopsy 84 90 1512 1518 B-treatment

Platelets 0 9 1519 1528 B-clinical_variable
≥ 10 11 1529 1530 O
100,000 12 19 1531 1538 B-lower_bound
cells 20 25 1539 1544 I-lower_bound
/ 25 26 1544 1545 I-lower_bound
mm3 26 29 1545 1548 I-lower_bound

Previous 0 8 1549 1557 O
or 9 11 1558 1560 O
concurrent 12 22 1561 1571 O
cytotoxic 23 32 1572 1581 B-treatment
chemotherapy 33 45 1582 1594 I-treatment
for 46 49 1595 1598 O
prostate 50 58 1599 1607 B-cancer
cancer 59 65 1608 1614 I-cancer

Prior 0 5 1615 1620 B-treatment
prostate 6 14 1621 1629 I-treatment
cancer 15 21 1630 1636 I-treatment
therapy 22 29 1637 1644 I-treatment
such 30 34 1645 1649 O
as 35 37 1650 1652 O
: 37 38 1652 1653 O
prostatectomy 39 52 1654 1667 B-treatment
, 52 53 1667 1668 O
cryotherapy 54 65 1669 1680 B-treatment
, 65 66 1680 1681 O
or 67 69 1682 1684 O
hyperthermia 70 82 1685 1697 B-chronic_disease

Prior 0 5 1698 1703 B-treatment
radiotherapy 6 18 1704 1716 I-treatment
to 19 21 1717 1719 I-treatment
the 22 25 1720 1723 I-treatment
pelvic 26 32 1724 1730 I-treatment
area 33 37 1731 1735 I-treatment

Prior 0 5 1736 1741 O
systemic 6 14 1742 1750 B-treatment
therapy 15 22 1751 1758 I-treatment
( 23 24 1759 1760 O
chemotherapy 24 36 1760 1772 B-treatment
) 36 37 1772 1773 O
for 38 41 1774 1777 O
prostate 42 50 1778 1786 B-cancer
cancer 51 57 1787 1793 I-cancer

Prostate 0 8 1794 1802 B-clinical_variable
specific 9 17 1803 1811 I-clinical_variable
antigen 18 25 1812 1819 I-clinical_variable
( 26 27 1820 1821 I-clinical_variable
PSA 27 30 1821 1824 I-clinical_variable
) 30 31 1824 1825 I-clinical_variable
< 32 33 1826 1827 O
20 34 36 1828 1830 B-upper_bound
ng 37 39 1831 1833 I-upper_bound
/ 39 40 1833 1834 I-upper_bound
mL 40 42 1834 1836 I-upper_bound
within 43 49 1837 1843 O
90 50 52 1844 1846 B-upper_bound
days 53 57 1847 1851 I-upper_bound
prior 58 63 1852 1857 I-upper_bound
to 64 66 1858 1860 O
registration 67 79 1861 1873 O

Regional 0 8 1874 1882 B-cancer
lymph 9 14 1883 1888 I-cancer
node 15 19 1889 1893 I-cancer
involvement 20 31 1894 1905 O

The 0 3 1906 1909 O
use 4 7 1910 1913 O
of 8 10 1914 1916 O
transfusion 11 22 1917 1928 O
or 23 25 1929 1931 O
other 26 31 1932 1937 O
intervention 32 44 1938 1950 O
to 45 47 1951 1953 O
achieve 48 55 1954 1961 O
Hgb 56 59 1962 1965 B-clinical_variable
≥ 60 61 1966 1967 O
8.0 62 65 1968 1971 B-lower_bound
g 66 67 1972 1973 I-lower_bound
/ 67 68 1973 1974 I-lower_bound
dl 68 70 1974 1976 I-lower_bound

